Edition:
United Kingdom

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

4.03USD
13 Jul 2018
Change (% chg)

$0.12 (+3.21%)
Prev Close
$3.90
Open
$3.85
Day's High
$4.05
Day's Low
$3.85
Volume
28,606
Avg. Vol
100,026
52-wk High
$5.80
52-wk Low
$2.35

Chart for

About

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's... (more)

Overall

Beta: 0.45
Market Cap(Mil.): $165.38
Shares Outstanding(Mil.): 31.35
Dividend: --
Yield (%): --

Financials

  ADMP.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.89 -- --
ROI: -68.80 15.07 14.61
ROE: -79.58 16.60 16.34

BRIEF-Adamis Pharmaceuticals Updates Symjepi Commercialization Plans

* ADAMIS PHARMACEUTICALS UPDATES SYMJEPI COMMERCIALIZATION PLANS

23 Feb 2018

BRIEF-Adamis Pharmaceuticals Announces FDA Acceptance For Review For The  Supplemental New Drug Application

* ADAMIS PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE FOR REVIEW FOR THE SUPPLEMENTAL NEW DRUG APPLICATION OF ITS LOW DOSE SYMJEPI PRODUCT CANDIDATE

12 Feb 2018

Competitors

  Price Chg
GlaxoSmithKline plc (GSK.L) 1,576.00 -0.60

Earnings vs. Estimates